OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Menthol USP 5.0% Pain reliever
Active Ingredients Purpose
Menthol USP 5.0% Pain reliever
Uses: Temporarily relieves minor aches and pains associated with
Keep out of reach of children. In case of accidental ingestion get medical help or contact a Poison Control Center immediately.
Stop use and ask a doctor if: Condition worsens or symptoms persist for more than 7 days or clear up and recur
Warnings: For external use only
When using this product: use only as directed
Directions:Adults and children over the age of 2 years old: Apply generously with gentle rubbing to the affected area 2-3 times daily or as needed.
Children less than 2 years of age: Consult a doctor
Inactive ingredients: Alcohol, Water, Glycerin, Hamamelis Virginiana (Witch Hazel) Bark/Leaf/Twig Extract, Arnica Montana Flower Extract, Acrylates/ C10-30 Alkyl Acrylate Crosspolymer, Aminomethyl Propanol, Mentha Piperita (Peppermint) Oil, Magnesium Sulfate, Cannabis Sativa Seed Oil, t-Butyl Alcohol, Phenoxyethanol, Ethylhexylglycerin, Propanediol, 1,2-Hexanediol, Caprylhydroxamic Acid
Broad Spectrum Hemp CBD
Cooling Roll On Relief
Net Contents: 3 fl. oz. (89ml)
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83262-005-01 | Magsoothium CBD Cooling Roll on Relief | 89 mL in 1 BOTTLE, WITH APPLICATOR | LIQUID | 89 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 83262-005 | 83262-005-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Magsoothium CBD Cooling Roll on Relief | MENTHOL | Ubu/Elements, Inc. | 2cf05dcd-6a44-de08-e063-6394a90aaba0 | 2025-01-30 | Warnings | 83262-005-01 83262-005 83262000501 2cf05dcd-6a45-de08-e063-6394a90aaba0 2cf05dcd-6a44-de08-e063-6394a90aaba0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.